Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 10;147(1):97.
doi: 10.1007/s00401-024-02750-w.

Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease

Feng Gao #  1   2 , Mengguo Zhang #  3 , Qiong Wang  3 , Ming Ni  4 , Chang Liu  5 , Kexue Deng  5 , Qiang Xie  4 , Shicung Wang  4 , Jiong Shi  3 , Yong Shen  6   7   8 ; For CANDI Consortium
Affiliations

Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease

Feng Gao et al. Acta Neuropathol. .

Abstract

Β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) is a crucial protease in the production of amyloid-β (Aβ) in Alzheimer's disease (AD) patients. However, the side effects observed in clinical trials of BACE1 inhibitors, including reduction in brain volume and cognitive worsening, suggest that the exact role of BACE1 in AD pathology is not fully understood. To further investigate this, we examined cerebrospinal fluid (CSF) levels of BACE1 and its cleaved product sAPPβ that reflects BACE1 activity in the China Aging and Neurodegenerative Disorder Initiative cohort. We found significant correlations between CSF BACE1 or sAPPβ levels and CSF Aβ40, Aβ42, and Aβ42/Aβ40 ratio, but not with amyloid deposition detected by 18F-Florbetapir PET. Additionally, CSF BACE1 and sAPPβ levels were positively associated with cortical thickness in multiple brain regions, and higher levels of sAPPβ were linked to increased cortical glucose metabolism in frontal and supramarginal areas. Interestingly, individuals with higher baseline levels of CSF BACE1 exhibited slower rates of brain volume reduction and cognitive worsening over time. This suggests that increased levels and activity of BACE1 may not be the determining factor for amyloid deposition, but instead, may be associated with increased neuronal activity and potentially providing protection against neurodegeneration in AD.

Keywords: Alzheimer’s disease; BACE1; Neurodegeneration; PET imaging.

PubMed Disclaimer

References

    1. Bao H, Liu Y, Zhang M, Chen Z, Zhang W, Ge Y et al (2021) Increased β-site APP cleaving enzyme 1-mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment. Alzheimers Dement 17:1097–1108. https://doi.org/10.1002/alz.12276 - DOI - PubMed
    1. Bao H, Shen Y (2023) Unmasking BACE1 in aging and age-related diseases. Trends Mol Med 29:99–111. https://doi.org/10.1016/j.molmed.2022.11.008 - DOI - PubMed
    1. Bernal-Rusiel JL, Greve DN, Reuter M, Fischl B, Sabuncu MR (2013) Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models. Neuroimage 66:249–260. https://doi.org/10.1016/j.neuroimage.2012.10.065 - DOI - PubMed
    1. Bernal-Rusiel JL, Reuter M, Greve DN, Fischl B, Sabuncu MR (2013) Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data. Neuroimage 81:358–370. https://doi.org/10.1016/j.neuroimage.2013.05.049 - DOI - PubMed
    1. Cacciaglia R, Salvadó G, Molinuevo JL, Shekari M, Falcon C, Operto G et al (2022) Age, sex and APOE-ε4 modify the balance between soluble and fibrillar β-amyloid in non-demented individuals: topographical patterns across two independent cohorts. Mol Psychiatry 27:2010–2018. https://doi.org/10.1038/s41380-022-01436-7 - DOI - PubMed - PMC

Publication types

MeSH terms

LinkOut - more resources